Grantclosed🌐 United StatesPAR-21-321

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Oct 12, 2021
Response deadline: Jan 7, 2026, 12:00 AM UTC
Type: Grant
Category: 93.172
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-21-321

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
United States · Nov 4, 2019
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
United States · Oct 18, 2024
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
United States · Dec 31, 2024
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
United States · Dec 31, 2024
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
United States · Dec 31, 2024
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
United States · Dec 28, 2022

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.